Bharat Biotech Ends Brazil Agreement With 2 Firms Amid Political Row | Read

PUBLISHED ON: July 24, 2021 | Duration: 0 min, 44 sec

  
loading..
Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of the made-in-India COVID-19 vaccine Covaxin.
ALSO WATCH
दुनिया का पहला DNA आधारित टीका, ZyCov-D को मिली मंजूरी

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com